Canland Health Announces Closing of Non-Brokered Private Placement

VANCOUVER, BC / ACCESSWIRE / October 22, 2019 / Canland Health Corp. (the “Company”) today announced that it has closed the previously announced non-brokered private placement (the “Private Placement”) raising gross proceeds of $365,000 from the issuance and sale of 3,650,000 common shares (“Common Shares”) at a price of $0.10 per Common Share. No new insiders were created as a result of this Private Placement.

The Private Placement was previously announced on October 17, 2019.

The Common Shares issued under the Private Placement will be subject to a four month and one day resale restriction. The Company intends to use the net proceeds of the Private Placement for evaluating new opportunities as part of its business model and for working capital purposes.

For further information regarding this news release contact:

C.K. Cheung, CEO
Tel: 416 904 1478

On behalf of the Board of Directors

CANLAND HEALTH CORP.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATED SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/563796/Canland-Health-Announces-Closing-of-Non-Brokered-Private-Placement

Staff

Recent Posts

Genflow Biosciences PLC Announces Publication of a Key European Patent

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION…

1 hour ago

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…

10 hours ago

Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…

10 hours ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…

10 hours ago

Music’s Healing Influence on Our Physiology

Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…

13 hours ago

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…

13 hours ago